Family Medicine Doctors in Rittman, OH Accepting Medicare
3 Family Medicine doctors found. Showing 1 - 3
 Dr. Darrell Leroy Widmer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 25 S Main St, Suite B, Rittman, OH 44270 Phone: 330-925-3857 Fax: 330-925-4016 |
Dr. Eugene Francis Petrilla, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 223 N Main St, Rittman, OH 44270 Phone: 330-925-4911 Fax: 330-927-9258 |
Dr. Paul Ernest Fracasso, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 223 N Main St, Rittman, OH 44270 Phone: 330-925-4911 Fax: 330-927-9258 |
News Archive
UMass Amherst scientist investigates how nitrogen in human milk may benefit pediatric development
David Sela, a nutrition scientist at the University of Massachusetts Amherst, has received a five-year, $1.69 million grant from the National Institutes of Health (NIH) to investigate how nitrogen in human milk is used by beneficial microbes in the infant gut to potentially play an important role in pediatric nutrition and development.
New research suggests closantel drug may be useful in combating river blindness
Scientists at The Scripps Research Institute have discovered a potential new use for the drug closantel, currently the standard treatment for sheep and cattle infected with liver fluke. The new research suggests that the drug may be useful in combating river blindness, a tropical disease that is the world's second leading infectious cause of blindness for humans.
Small businesses face higher premiums, push for access to 'exchanges'
"As Congress nears votes on legislation that would overhaul the health care system, many small businesses say they are facing the steepest rise in insurance premiums they have seen in recent years," the New York Times reports.
Hormonal therapies for breast and prostate cancers increase the risk of heart attack, stroke
The hormonal therapies used to treat many breast and prostate cancers raise the risk of a heart attack and stroke, and patients should be monitored regularly and receive treatment to reduce risk and detect problems as they occur.
FDA warning letter to Genzyme related to Allston manufacturing facility
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today that the FDA warning letter issued to Genzyme addressing deficiencies related to Genzyme's Allston Landing manufacturing facility during an inspection performed in September and October 2008 has no foreseeable impact on the supply of Aldurazyme.
› Verified 7 days ago